Article
Next-generation bNAbs for HIV-1 cure strategies
28 Dec 2023
Abstract excerpt
Despite the ability to suppress viral replication using anti-retroviral therapy (ART), HIV-1 remains a global public health problem. Curative strategies for HIV-1 have to target and eradicate latently infected cells across the body, i.e. the viral reservoir. Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) have the capacity to neutralize virions and bind to infected cells to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
